Trial Profile
Phase I trial of COL 172, an extended-release formulation of oxymorphone
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 30 Mar 2010
Price :
$35
*
At a glance
- Drugs Oxymorphone (Primary)
- Indications Pain
- Focus Adverse reactions
- 30 Mar 2010 New trial record